Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array-based solutions for genetic research
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Front Line Genomics Media Production | Other 6 Nov 2023 | | ||
UK Biobank deeptech, healthtech, Research Services | Other 5 Dec 2023 | | ||
Nature Portfolio Book and Periodical Publishing | Other 29 Nov 2023 | | ||
Biocom California Biotechnology Research | Other 18 Dec 2023 | | ||
CosmosID biotech, deeptech, healthtech, Biotechnology Research | Not capitalistic Not partnership Event 1 Jun 2023 | | ||
Syapse biotech, deeptech, healthtech, IT Services, IT Services and IT Consulting | Other 21 Oct 2023 | | ||
Helix biotech, deeptech, healthtech, martech, Hospitals and Health Care | Other 25 Mar 2023 | | ||
Juno Bio healthtech, Biotechnology Research | Not capitalistic Not partnership Event 30 Nov 2021 | | ||
Center for Genomic Interpretation biotech, deeptech, Hospitals and Health Care | Other 31 Jan 2023 | | ||
Envisagenics biotech, deeptech, Biotechnology Research | Other 19 Nov 2022 | |